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Efﬁcacy of percutaneous interventions in
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Background: The aim of study was to clarify the biochemical
mechanisms of severe hemorrhagic forms of erysipelas and ﬁnd
the possible early predictors of its development.
Methods & Materials: A puncture in patients with hepatic
echinococcosis was performed using ultrasonic control. Percu-
taneous drainage was performed under ﬂuoroscopic control.
Protoscolicidal processing and cyst shells degradation were per-
formed with 1% aqueous solution of hypochlorous solution. After
percutaneous intervention the patients had received conducted
anti-relapse therapy with albendazole (800 mg/day, 3 courses
within 28 days with an interval of 14 days).
Results: During 2004-2015 transdermal interventions were
performed in 58 patients (37women, 21men in the a age of 53 +/- 4
years)with liver cysts. Single cystswere in30 (51.7%) patients,mul-
tiple in 28 (48.3%). The maximum number of cysts in one patient
was 10. According to the ultrasonic and CT maximum longitudinal
size of the cysts ranged from 9 mm to 167mm. Totally it was per-
formed 91 percutaneous interventions, 27 punctures, 64 drainages.
44 percutaneous intervention were performed for cysts type
I (according to the classiﬁcation of Gharbi), 6 – for type II, 28 –
for type III, 5 – for type IV, 8 – for type V. The effectiveness of
percutaneous treatment was - 98.2% (57 patients). Intraoperative
complications (allergic-type urticaria) were observed in 2 (3.4%)
patients. Surgical complications in the postoperative period were
recorded in 16 patients (28.1%) patients: external biliary ﬁstula
in 9 (15.8%), bleeding cavity of cyst in 1 (1.8%), suppuration of
the residual cavity in 1 (1.8%), bile-bronchial ﬁstula in 1 (1.8%). 4
(7%) patients had external biliary ﬁstula in combination with sup-
puration of the residual cavity in 2 (3.5%) and bleeding cyst in 2
(3.5%). Complications have been cropped with conservative ther-
apy. Relapse was observed in 1 (1.7%) patients who did not receive
anti-relapse therapy.
Recurrent 34 months after puncture of echinococcus cyst
cyst before puncture
34 months after puncture of echinococcus cyst
Conclusion: The results showed high effectiveness of
echinococcosis treatment with percutaneous interventions and
conservative therapywith albendazole and using as protoscolicidal
preparation 1% sodium hypochlorite.
http://dx.doi.org/10.1016/j.ijid.2016.02.807
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Background: Diroﬁlariasis is the only vector-borneworm infec-
tion in countries with a temperate climate. Novgorod Region is
the northern border of diroﬁlariasis habitat in Russia. The ﬁrst
indigenous case of diroﬁlariasiswas registered in 2011 inNovgorod
Region.
Methods & Materials: Study was conducted in the period from
November 2010 to July 2015. We investigated 235 samples of dog
blood. Samples assaywas conductedby concentrationmethodwith
3% acetic acid. We studied 438 female mosquitoes.
Results: In medical network of Novgorog region 11 cases of
infestation of humans by Diroﬁlaria repens were observed dur-
ing this period. In all cases parasites were identiﬁed as immature
femaleswith 120-140mmof body length and itswidth of bodywas
0.4 to 0.5 mm.
The infestationbydiroﬁlariasiswas identiﬁed in59 (25,1%)dogs.
Of 235 surveyed animals 81 were the service dogs belonged to
the Ministry of Internal Affairs. We revealed a high infestation
of the service dogs by Diroﬁlaria repens (34,6%). The course of
anthelmintic drugs was administered to service dogs. During the
follow-up period of one month after treatment a 5.1% decrease of
the infestation by diroﬁlariasis has been found in the service dogs.
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During the observation period infection of female mosquitoes
was decreased from 0,9% in 2011 to 0,3% in 2014.
Conclusion: Studies have shown that in the Novgorod region
adoptable conditions are present for formation of the foci of diro-
ﬁlariasis. Detection of human diroﬁlariasis in Northwest of Russia
has been associated with delivery of infected service dogs of Min-
istry of Internal Affairs. Service dogs are regularly seconded towork
in the heartworm-endemic territories regions like as North Cauca-
sus or Southern Russia. In our view, the circulation of Diroﬁlaria
repens in the Novgorod region supports a high number of infected
dogs and a lot of vectors of transmission. Abnormally warm sum-
mers of 2010 and 2011 contributed to the development of several
generations of larvae vector transmission. These factors could lead
to the forming the foci diroﬁlariasis in the Novgorod region and the
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Antibodies to plasmodium falciparum glutamic
acid rich protein (PfGARP) inhibit parasite
growth by arresting trophozoite development
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Background: Malaria affects almost one-half of the world’s
population and causes more than 600,000 deaths annually. Young
children in malaria endemic areas of Africa have the highest mor-
tality rate because of their immature immune systems. In previous
vaccine discovery efforts, we developed a differential screening
method using plasma from children who were resistant or sus-
ceptible to falciparum malaria. Using this approach, we discovered
PfSEA-1. Antibodies to PfSEA-1 predict resistance to severe dis-
ease in two yr old children, block schizont egress from infected
RBC in vitro, and vaccination with rPbSEA-1A protects mice from P.
berghei ANKA challenge (Raj et. al Science 2014).
Methods & Materials: We have now adapted our differen-
tial screening method to ﬁeld parasite-derived phage display
libraries. In differential bio-panning assays, PfGARP (aa 410-673)
was recognizedbyplasmapooled fromresistant (n=11) butnot sus-
ceptible (n=14) childrenparticipating inourbirthcohort inMuheza,
Tanzania. To further characterize PfGARP, we generated mouse
antibodies against this immuno-relevant, highly invariant region
(PfGARP-A) and performed growth inhibition (GIA) and immunolo-
calization studies. For GIA, 3D7 parasites were synchronized to the
ring stage and plated at 0.3-0.4% parasitemia in the presence of
anti-PfGARP-A or pre-immune sera (1:10 dilution). Parasites were
cultured for 48 hrs and ring and early trohozoite stage parasites
were enumerated.
Schematic of phase display technique
Results: Anti-PfGARP-A inhibited parasite growth by 99% com-
pared to controls (P<0.001). In confocal studies, PfGARP localized to
the RBCmembrane in trophozoite and early schizont infected RBCs,
but not to other parasite stages or uninfected RBC. To determine
the mechanism of growth inhibition we performed trophozoite
arrest assays (TAA) using anti-PfGARP-A. For TAA, 3D7 parasites
were synchronized to the ring stage and plated at 5% parasitemia
in the presence of anti-PfGARP-A or pre-immune mouse sera (1:10
dilution). Parasites were cultured for 36 hrs and trophozoite stage
parasites were enumerated. Anti-PfGARP-A arrested trophozoite
progression by 99% compared to controls (P < 0.001)
Localization of PfGARP
Growth Inhibition Assay
Conclusion: These data support Pf-GARP as a novel vaccine can-
didate for pediatric falciparum malaria. By blocking trophozoite
development, PfGARP may synergize with vaccines targeting hep-
atocyte and red cell invasion and schizont egress.
http://dx.doi.org/10.1016/j.ijid.2016.02.809
